BridgeBio Pharma Inc (BBIO)

개요 뉴스 가격 이력 옵션 체인 Financials BBIO 왜 하락? 토론 예측

왜 BridgeBio Pharma Inc (BBIO) 주가가 하락하고 있습니까?

2024-04-12 거래 세션 동안 BridgeBio Pharma Inc(BBIO) 주식이 5.39% 하락한 것을 확인했습니다. 이는 정상적인 변동성이나 다양한 내부 및 외부 요인에 의한 것일 수 있지만, 상황을 적극적으로 모니터링하고 있으며 최대한 빨리 적시에 업데이트를 제공하도록 하겠습니다!

2024-03-04:

BridgeBio Pharma Inc (BBIO) stock declined by 9.19% due to the announcement of a $250 million public offering.

Offering details: The offering, totaling $250 million of shares of its common stock, aims to grant the underwriters a 30-day option to purchase up to an additional $37.5 million of shares. All shares in the proposed offering will be sold by BridgeBio.
Reasons for the Decline: The offering news likely caused the stock price to pull back due to dilution concerns. When the company issues new shares, it can dilute the ownership stake of existing shareholders, leading to a decrease in the stock price. Investors may also be cautious about the potential impact of the offering on BridgeBio's financials and future growth prospects.

2023-06-15:

BBIO's stock fell 8.11% following a cautious note by JPMorgan Chase regarding the biotech's experimental treatment of symptomatic transthyretin amyloidosis cardiomyopathy, or ATTR-CM, known as acoramidis. JPMorgan's team considered this a "high-risk" event due to the well-documented difficulty in treating patients with this condition.

https://www.fool.com/investing/2023/06/15/why-bridgebio-pharma-stock-is-plunging-today/